Ascendis Pharma A/S Reversal Of Inventory Writedown
Ascendis Pharma A/S (ASND) reported Reversal Of Inventory Writedown of EUR 53.70 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-02.
Discontinued › Notes
ifrs-full:ReversalOfInventoryWritedown · last filed 2022-03-02
| Period end | Reversal Of Inventory Writedown 12 month |
|---|---|
| 2021-12-31 | 53.70M EUR 20-F · filed 2022-03-02 |